Fakhar Ijaz, MD
Nephrology · Little Rock, ARNPI 1487653820
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $315 and has fallen 55.8% since, to $139 in 2025.
Across 83 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$268
- GSK$212
- Fresenius USA Marketing, Inc.$176
- Amgen$161
- Mallinckrodt Hospital Products Inc.$144
- Ardelyx, Inc.$117
- plus $489 from 10 others
What the payments were for
- Food & beverage$1,42791%
- Education$1399%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 16 | $268 |
| GSK | 13 | $212 |
| Fresenius USA Marketing, Inc. | 9 | $176 |
| Amgen | 7 | $161 |
| Mallinckrodt Hospital Products Inc. | 6 | $144 |
| Ardelyx, Inc. | 4 | $117 |
| Otsuka America Pharmaceutical, Inc. | 3 | $114 |
| Bayer | 4 | $82 |
| Mallinckrodt Enterprises LLC | 4 | $62 |
| Calliditas Therapeutics US Inc. | 3 | $58 |
| Travere Therapeutics, Inc. | 7 | $44 |
| OPKO Pharmaceuticals, LLC | 2 | $40 |
| Aurinia Pharma U.S., Inc. | 2 | $36 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Vifor Pharma, Inc. | 1 | $18 |
| Akebia Therapeutics Inc | 1 | $15 |
How this compares
$1,566 in reported general payments places this provider in the 55th percentile of 85 nephrology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 16 | $29,600 |
| Sevelamer Carbonate | 27 | $3,825 |
| Calcium Acetate | 72 | $2,196 |
| Nifedipine ErNifedipine | 34 | $921 |
| Midodrine Hcl | 22 | $457 |
| Furosemide | 70 | $314 |
| Ondansetron Hcl | 14 | $202 |
| Hydralazine Hcl | 29 | $192 |
| Carvedilol | 75 | $181 |
| Losartan Potassium | 21 | $133 |
| Pantoprazole Sodium | 22 | $82 |
| Cephalexin | 12 | $74 |
| Atorvastatin Calcium | 23 | $72 |
| ClopidogrelClopidogrel Bisulfate | 13 | $46 |
| Amlodipine Besylate | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $176 | $29,60016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 85 nephrology providers in Arkansas.
Other nephrology in Little Rock
- Luis JuncosLittle Rock$66K
- John HeifnerLittle Rock$45K
- John ArthurLittle Rock$7K
- Moses EjioforLittle Rock$6K
- Alex DavidLittle Rock$6K
- Prajwal ChevireddyLittle Rock$3K
- Muhammad AlamLittle Rock$2K
- Kashaf RasheedLittle Rock$2K
- Nithin KarakalaLittle Rock$739
- Garry GlascoLittle Rock$459
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.